Journal article
Edoxaban for treatment of venous thromboembolism in patients with cancer
Abstract
Direct oral anticoagulants may be effective and safe for treatment of venous thromboembolism (VTE) in cancer patients, but they have not been compared with low-molecular-weight heparin (LMWH), the current recommended treatment for these patients. The Hokusai VTE-cancer study is a randomised, open-label, clinical trial to evaluate whether edoxaban, an oral factor Xa inhibitor, is non-inferior to LMWH for treatment of VTE in patients with cancer. …
Authors
van Es N; Di Nisio M; Bleker SM; Segers A; Mercuri MF; Schwocho L; Kakkar A; Weitz JI; Beyer-Westendorf J; Boda Z
Journal
Thrombosis and Haemostasis, Vol. 114, No. 06, pp. 1268–1276
Publisher
Thieme
Publication Date
2015
DOI
10.1160/th15-06-0452
ISSN
0340-6245